FAQs

The CDD & AI for Biologics Summit is a specialist industry event focused on the convergence of computational drug design and AI/ML for biologics discovery, optimization and developability assessment. It is designed to help attendees understand how AI and computational approaches can be applied across biologics design, property prediction, multi-objective optimization, molecular dynamics, and early decision-making ahead of CMC.

CDD stands for computational drug design. This summit explores how computational approaches and AI/ML can be used together to accelerate biologics discovery, design, optimization, and developability assessment.

This summit is built for computational biologists, data scientists, developability specialists, AI/ML innovation leads, biologics discovery scientists, and related R&D professionals across pharma, biotech, techbio, academia, and research institutes. It is particularly relevant for teams working on biologics design, antibody engineering, protein design, property prediction, molecular simulation, and AI-enabled discovery workflows.

Attendees join to learn from real-world, experimentally validated use cases at the intersection of AI and computation for biologics, while also networking with peers from pharma, biotech, techbio, and academia. The summit is designed to help delegates understand how AI/ML can be operationalized in biologics discovery workflows and used to support candidate progression toward derisked CMC and proof of therapeutic value.